RAD 205
Alternative Names: RAD-205Latest Information Update: 09 Mar 2022
At a glance
- Originator Radiopharm Theranostics
- Class Antineoplastics; Immunoconjugates; Radioisotopes; Radiopharmaceuticals; Single-domain antibodies
- Mechanism of Action Ionising radiation emitters
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Preclinical Breast cancer
Most Recent Events
- 03 Feb 2022 Preclinical trials in Cancer in Australia (IV) (Radiopharm Theranostics pipeline; February 2022)